• Citer

Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2 -Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials

par Fernandez-Martinez, Aranzazu;Rediti, Mattia ;Tang, Gong;Pascual, Tomás;Hoadley, Katherine K.A.;Venet, David ;Rashid, Naim N.U.;Spears, Patricia P.A.;Islam, Md Naimul;El-abed, Sarra;Bliss, Judith M;Lambertini, Matteo Md Phd M.;Di Cosimo, Serena;Huobe, Jens;Goerlitz, David;Hu, Rong;Lucas, Peter P.C.;Swain, Sandra S.M.;Sotiriou, Christos ;Perou, Charles C.M.;Carey, Lisa L.A.
Référence JAMA oncology
Publication Publié, 2024

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2 -Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials
Auteur:	Fernandez-Martinez, Aranzazu; Rediti, Mattia; Tang, Gong; Pascual, Tomás; Hoadley, Katherine K.A.; Venet, David; Rashid, Naim N.U.; Spears, Patricia P.A.; Islam, Md Naimul; El-abed, Sarra; Bliss, Judith M; Lambertini, Matteo Md Phd M.; Di Cosimo, Serena; Huobe, Jens; Goerlitz, David; Hu, Rong; Lucas, Peter P.C.; Swain, Sandra S.M.; Sotiriou, Christos; Perou, Charles C.M.; Carey, Lisa L.A.
Informations sur la publication:	JAMA oncology
Statut de publication:	Publié, 2024
Sujet CREF:	Généralités
MeSH keywords:	Adult
	Aged
	Female
	Humans
	Middle Aged
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Biomarkers, Tumor -- genetics
	Breast Neoplasms -- drug therapy -- genetics -- pathology
	Gene Expression Profiling
	Lapatinib -- administration & dosage -- therapeutic use
	Neoadjuvant Therapy
	Neoplasm Staging
	Receptor, ErbB-2 -- genetics
	Retrospective Studies
	Transcriptome
	Trastuzumab -- therapeutic use -- administration & dosage
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2374-2437
	info:doi/10.1001/jamaoncol.2023.7304
	info:pii/2816978
	info:scp/85189652930
	info:pmid/38546612
	PMC10979363